Neurological side effects of SARS‐CoV‐2 vaccinations
J Finsterer - Acta Neurologica Scandinavica, 2022 - Wiley Online Library
SARS‐CoV‐2 and adverse reactions to SARS‐CoV‐2 vaccinations show a tropism for
neuronal structures and tissues. This narrative review was conducted to collect and discuss …
neuronal structures and tissues. This narrative review was conducted to collect and discuss …
[HTML][HTML] A review of neurological side effects of COVID-19 vaccination
R Hosseini, N Askari - European Journal of Medical Research, 2023 - Springer
Following the COVID-19 virus epidemic, extensive, coordinated international research has
led to the rapid development of effective vaccines. Although vaccines are now considered …
led to the rapid development of effective vaccines. Although vaccines are now considered …
[HTML][HTML] The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
Vaccines based on mRNA-containing lipid nanoparticles (LNPs) are a promising new
platform used by two leading vaccines against COVID-19. Clinical trials and ongoing …
platform used by two leading vaccines against COVID-19. Clinical trials and ongoing …
[HTML][HTML] Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs
S Seneff, G Nigh, AM Kyriakopoulos… - Food and Chemical …, 2022 - Elsevier
Abstract The mRNA SARS-CoV-2 vaccines were brought to market in response to the public
health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious …
health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious …
A systematic review of cases of CNS demyelination following COVID-19 vaccination
II Ismail, S Salama - Journal of neuroimmunology, 2022 - Elsevier
Background Since the emergency use approval of different types of COVID-19 vaccines,
several safety concerns have been raised regarding its early and delayed impact on the …
several safety concerns have been raised regarding its early and delayed impact on the …
[HTML][HTML] The side effects and adverse clinical cases reported after COVID-19 immunization
COVID-19 remains a deadly disease that poses a serious threat to humanity. COVID-19
vaccines protect the public and limit viral spread. However, public acceptance is significantly …
vaccines protect the public and limit viral spread. However, public acceptance is significantly …
New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure
Background Multiple sclerosis (MS) with onset in the setting of acute SARS-CoV-2 virus
infection has been reported, and reactivation of MS following non-mRNA COVID-19 …
infection has been reported, and reactivation of MS following non-mRNA COVID-19 …
[HTML][HTML] Current evidence in SARS-CoV-2 mRNA vaccines and post-vaccination adverse reports: knowns and unknowns
DS Mouliou, E Dardiotis - Diagnostics, 2022 - mdpi.com
The novel mRNA vaccinations against COVID-19 are gaining worldwide attention for their
potential efficacy, as well as for the diagnosis of some post-vaccination-reported adverse …
potential efficacy, as well as for the diagnosis of some post-vaccination-reported adverse …
[HTML][HTML] mRNA: vaccine or gene therapy? The safety regulatory issues
H Banoun - International Journal of Molecular Sciences, 2023 - mdpi.com
COVID-19 vaccines were developed and approved rapidly in response to the urgency
created by the pandemic. No specific regulations existed at the time they were marketed …
created by the pandemic. No specific regulations existed at the time they were marketed …
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: a systematic review
Background The global COVID-19 pandemic began in March 2019, and given the number of
casualties and adverse effects on the economy, society, and all aspects of the health system …
casualties and adverse effects on the economy, society, and all aspects of the health system …